Fulcrum Therapeutics, Inc. /
Slate Medicines, Inc.
Fulcrum Therapeutics, Inc. signed an agreement for Slate Medicines, Inc.
Source for the buyer and target: Fulcrum Therapeutics, Inc.
For the buyer and target.
“Agreement and Plan of Merger, dated as of August 16, 2026, by and among Fulcrum Therapeutics, Inc., Fusion Merger Sub I, Inc., Fusion Merger Sub II, LLC and Slate Medicines, Inc.”
Published 17 Aug 2026
Open the sourceWhat happened
The deal for Slate Medicines, Inc. is signed, with Fulcrum Therapeutics, Inc. as the buyer, at a stated price of $350.0 million. [01]
The filing from Fulcrum Therapeutics, Inc. is dated Aug. 17, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Fulcrum Therapeutics, Inc. signed an agreement for Slate Medicines, Inc.
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly